Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Gilead characterizes bifunctional LABA/PDE4 inhibitor

June 14, 2012

Novel prognostic marker for cervical cancer correlates with EGFR expression

June 14, 2012

Novel dipeptidyl peptidase IV inhibitor shows promise in diabetes/obesity models

June 13, 2012

First-in-human data disclosed on gene-modified T cells to facilitate stem cell transplants

June 13, 2012

Phase I results encourage continued clinical evaluation of PEGylated C-peptide

June 13, 2012

Novel data reported on GKM-001 in diabetes and obesity

June 13, 2012

SIRT1 activation investigated in models of obesity

June 13, 2012

Ubidecarenone investigated for oncolytic activity

June 12, 2012

U.S. study reveals microRNAs with prognostic significance in kidney cancer

June 12, 2012

Phase I and II trials assess Gradalis cancer vaccines

June 12, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...